Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00175864
Status:
WITHDRAWN
Last Update Posted:
2012-03-20
First Post:
2005-09-09
Brief Title:
Open Label Study Everyone Who Participates Receives Drug to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
N01212
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None